Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Drakon™ and Sequre® Microcatheters

K-Number: K231293 · 2023-06-01

Decision Date2023-06-01
Product CodeDQO
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Drakon™ and Sequre® Microcatheters is a medical device manufactured by Accurate Medical Therapeutics. It received FDA 510(k) clearance on 2023-06-01 under approval number K231293. The device is classified under product code DQO. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Drakon™ and Sequre® Microcatheters?

Drakon™ and Sequre® Microcatheters is a medical device that received FDA 510(k) clearance on 2023-06-01. It is manufactured by Accurate Medical Therapeutics. The 510(k) number is K231293.

When was Drakon™ and Sequre® Microcatheters approved by the FDA?

Drakon™ and Sequre® Microcatheters received FDA 510(k) clearance on 2023-06-01, under approval number K231293.

What company makes Drakon™ and Sequre® Microcatheters?

Drakon™ and Sequre® Microcatheters is manufactured by Accurate Medical Therapeutics.

What is the FDA product code for Drakon™ and Sequre® Microcatheters?

The FDA product code for Drakon™ and Sequre® Microcatheters is DQO.

Related Devices (Code: DQO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.